Evaluation of switching from intravenous to subcutaneous formulation of tocilizumab in patients with rheumatoid arthritis

Iwamoto Naoki; Fukui Shoichi; Umeda Masataka; Nishino Ayako; Nakashima Yoshikazu; Suzuki Takahisa; Horai Yoshiro; Nonaka Fumiaki; Okada Akitomo; Koga Tomohiro; Kawashiri Shin-ya; Fujikawa Keita; Aramaki Toshiyuki; Ichinose Kunihiro; Hirai Yasuko; Tamai Mami; Nakamura Hideki; Terada Kaoru; Nakashima Munetoshi; Mizokami Akinari; Origuchi Tomoki; Eguchi Katsumi; Ueki Yukitaka; Kawakami Atsushi

首页> 外文期刊>Modern rheumatology >Evaluation of switching from intravenous to subcutaneous formulation of tocilizumab in patients with rheumatoid arthritis

【24h】

Evaluation of switching from intravenous to subcutaneous formulation of tocilizumab in patients with rheumatoid arthritis

机译：类风湿关节炎患者从托珠单抗由静脉给药改为皮下给药的评估

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Objective: To evaluate the efficacy of switching the route from intravenous tocilizumab (TCZ) infusion (TCZ-IV) to subcutaneous TCZ injection (TCZ-SC) in a real-world setting through a comparison of the clinical response.

机译：目的：通过比较临床反应，评估在现实世界中将静脉内托珠单抗（TCZ）输注（TCZ-IV）转换为皮下TCZ注射（TCZ-SC）的功效。

著录项

来源
《Modern rheumatology》 |2016年第5期|共5页
作者
Iwamoto Naoki; Fukui Shoichi; Umeda Masataka; Nishino Ayako; Nakashima Yoshikazu; Suzuki Takahisa; Horai Yoshiro; Nonaka Fumiaki; Okada Akitomo; Koga Tomohiro; Kawashiri Shin-ya; Fujikawa Keita; Aramaki Toshiyuki; Ichinose Kunihiro; Hirai Yasuko; Tamai Mami; Nakamura Hideki; Terada Kaoru; Nakashima Munetoshi; Mizokami Akinari; Origuchi Tomoki; Eguchi Katsumi; Ueki Yukitaka; Kawakami Atsushi;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类免疫性疾病;
关键词
Rheumatoid arthritis; Subcutaneous injection; Tocilizumab;

机译：类风湿关节炎;皮下注射;托珠单抗;

相似文献

外文文献
中文文献
专利

1. Evaluation of switching from intravenous to subcutaneous formulation of tocilizumab in patients with rheumatoid arthritis [J] . Iwamoto Naoki, Fukui Shoichi, Umeda Masataka, Modern rheumatology . 2016,第5期

机译：类风湿关节炎患者从托珠单抗由静脉给药改为皮下给药的评估
2. A randomised, double-blind, parallel-group study of the safety and efficacy of subcutaneous tocilizumab versus intravenous tocilizumab in combination with traditional disease-modifying antirheumatic drugs in patients with moderate to severe rheumatoid arthritis (SUMMACTA study) [J] . BurmesterG.R., Rubbert-RothA., CantagrelA., Annals of the Rheumatic Diseases: A Journal of Clinical Rheumatology and Connective Tissue Research . 2014,第1期

机译：对中度至重度类风湿性关节炎患者皮下使用tocilizumab与静脉使用tocilizumab联合传统的改变病情的抗风湿药的安全性和有效性的随机，双盲，平行研究（SUMMACTA研究）
3. A randomised, double-blind, parallel-group study of the safety and efficacy of subcutaneous tocilizumab versus intravenous tocilizumab in combination with traditional disease-modifying antirheumatic drugs in patients with moderate to severe rheumatoid arthritis (SUMMACTA study) [J] . BurmesterG.R., Rubbert-RothA., CantagrelA., Annals of the Rheumatic Diseases: A Journal of Clinical Rheumatology and Connective Tissue Research . 2014,第1期

机译：对中度至重度类风湿性关节炎患者皮下使用tocilizumab与静脉使用tocilizumab联合传统的改变病情的抗风湿药的安全性和有效性的随机，双盲，平行研究（SUMMACTA研究）
4. Hand range of motion evaluation for Rheumatoid Arthritis patients [C] . Luciano Walenty Xavier Cejnog, Roberto Marcondes Cesar, Teofilo E. de Campos, International Conference on Automatic Face and Gesture Recognition . 2019

机译：类风湿关节炎患者手部活动范围评估
5. Patient Treatment Priorities and Patient-Centered Care in Rheumatoid Arthritis [D] . Dibie, Chukwuebuka. 2020

机译：患者治疗优先事项和患者以类风湿性关节炎为中心护理
6. Tocilizumab Effectiveness After Switching from Intravenous to Subcutaneous Route in Patients with Rheumatoid Arthritis: The RoSwitch Study [O] . Jean Darloy, Nicolas Segaud, Jean-Hugues Salmon, 2019

机译：类风湿关节炎患者从静脉途径转换为皮下途径后的Tocilizumab有效性：RoSwitch研究
7. FRI0253 Patient-reported outcomes in patients with rheumatoid arthritis treated with subcutaneous tocilizumab compared with placebo or intravenous tocilizumab in combination with csdmards [O] . V Strand, K Lampl, C Birchwood, 2017

机译：与皮下或静脉内对CSDMARS组合的患者用皮下对硅酸钠治疗的类风湿性关节炎患者的患者报告的结果

Evaluation of switching from intravenous to subcutaneous formulation of tocilizumab in patients with rheumatoid arthritis

摘要

著录项

相似文献

相关主题

期刊订阅